Abstract: The present disclosure relates to certain AHR agonist compounds, for example, having a general formula (I) to pharmaceutical compositions comprising the compounds, and to methods of using the compounds to treat immune-mediated diseases, such as psoriasis and atopic dermatitis.
| # | Name | Date |
|---|---|---|
| 1 | 202517046219-STATEMENT OF UNDERTAKING (FORM 3) [14-05-2025(online)].pdf | 2025-05-14 |
| 2 | 202517046219-REQUEST FOR EXAMINATION (FORM-18) [14-05-2025(online)].pdf | 2025-05-14 |
| 3 | 202517046219-POWER OF AUTHORITY [14-05-2025(online)].pdf | 2025-05-14 |
| 4 | 202517046219-FORM 18 [14-05-2025(online)].pdf | 2025-05-14 |
| 5 | 202517046219-FORM 1 [14-05-2025(online)].pdf | 2025-05-14 |
| 6 | 202517046219-DECLARATION OF INVENTORSHIP (FORM 5) [14-05-2025(online)].pdf | 2025-05-14 |
| 7 | 202517046219-COMPLETE SPECIFICATION [14-05-2025(online)].pdf | 2025-05-14 |
| 8 | 202517046219-CLAIMS UNDER RULE 1 (PROVISIO) OF RULE 20 [14-05-2025(online)].pdf | 2025-05-14 |
| 9 | 202517046219-Proof of Right [24-06-2025(online)].pdf | 2025-06-24 |
| 10 | 202517046219-FORM 3 [24-06-2025(online)].pdf | 2025-06-24 |